Effects of Hydrochlorothiazide on the Pharmacokinetics, Pharmacodynamics, and Tolerability of Canagliflozin, a Sodium Glucose Co-transporter 2 Inhibitor, in Healthy Participants-Reference-Cited by-同舟云学术

Effects of Hydrochlorothiazide on the Pharmacokinetics, Pharmacodynamics, and Tolerability of Canagliflozin, a Sodium Glucose Co-transporter 2 Inhibitor, in Healthy Participants

Published:2014-05 Issue:5 Volume:36 Page:698-710
ISSN:0149-2918
Container-title:Clinical Therapeutics
language:en
Short-container-title:Clinical Therapeutics

Author:

Devineni Damayanthi,Vaccaro Nicole,Polidori David,Rusch Sarah,Wajs Ewa

Publisher

Elsevier BV

Subject

Pharmacology (medical),Pharmacology

Reference37 articles.

1. The role of the kidneys in glucose homeostasis: a new path towards normalizing glycaemia;Defronzo;Diabetes Obes Metab,2012

2. Role of sodium-glucose cotransporter 2 (SGLT 2) inhibitors in the treatment of type 2 diabetes;Abdul-Ghani;Endocr Rev,2011

3. Dose-ranging effects of canagliflozin, a sodium-glucose cotransporter 2 inhibitor, as add-on to metformin in subjects with type 2 diabetes;Rosenstock;Diabetes Care,2012

4. Efficacy and safety of canagliflozin monotherapy in subjects with type 2 diabetes mellitus inadequately controlled with diet and exercise;Stenlöf;Diabetes Obes Metab,2013

5. Efficacy and safety of canagliflozin in subjects with type 2 diabetes and chronic kidney disease;Yale;Diabetes Obes Metab,2013

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multicentric assessment of empagliflozin, sitagliptin and cholestyramine on n-2 streptozotocin diabe tic rats;Annals of Phytomedicine An International Journal;2024-07

2. Renoprotective effects of GLP-1 receptor agonists and SGLT-2 inhibitors—is hemodynamics the key point?;American Journal of Physiology-Cell Physiology;2023-07-01

3. Mathematical modeling of antihypertensive therapy;Frontiers in Physiology;2022-12-14

4. Benefits of Taking Sodium-Glucose Cotransporter 2 Inhibitors in Patients With Type 2 Diabetes Mellitus and Cardiovascular Disease: A Systematic Review;Cureus;2022-09-12

5. Glycaemic Control in Patients Undergoing Percutaneous Coronary Intervention: What Is the Role for the Novel Antidiabetic Agents? A Comprehensive Review of Basic Science and Clinical Data;International Journal of Molecular Sciences;2022-06-30